Wide range in age of onset for chromosome 1-related familial Alzheimer's disease

Annals of Neurology

Volumn 40, Issue 6, 1996, Pages 932-936

  Bird, Thomas D ^a,b,c   Levy Lahad, Ephrat ^b,d   Poorkaj, Parvoneh ^a   Sharma, Vikram ^a   Nemens, Ellen ^b   Lahad, Amnon ^b,e   Lampe, Thomas H ^a   Schellenberg, Gerard D ^a,e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c VA Puget Sound Heath Care System   (United States)

^d SHAARE ZEDEK MEDICAL CENTER   (Israel)

^e HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CHROMOSOME 1; CHROMOSOME 14; CONTROLLED STUDY; DISEASE DURATION; FAMILIAL DISEASE; FEMALE; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; ALZHEIMER DISEASE; APOLIPOPROTEINS E; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 21; ETHNIC GROUPS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION;

EID: 0030499031     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410400619     Document Type: Article

References (15)

1. Roses AD. Apolipoprocein E affects the rate of Alzheimer disease expression: β-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J Neuropathol Exp Neurol 1994;53:429-437
2. Goate A, Chartier-Harlin MC, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991;349:704-706
3. Sherrington R, Rogaev EI, Liang Y, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 1995;375:754-760
4. Levy-Lahad E, Wasco W, Poorkaj P, Romano, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995;269:973-977
5. Bird TD, Sumi SM, Nemens EJ, et al. Phenotypic heterogeneity in familial Alzheimer's disease: a study of 24 kindreds. Ann Neurol 1989;25:12-25
6. Bird TD, Lampe TH, Nemens EJ, et al. Familial Alzheimer's disease in American descendants of the Volga Germans: probable genetic founder effect. Ann Neurol 1988;23:23-31
7. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease. Neurology 1984;34:939-944
8. Van Broeckhoven C. Presenilins and Alzheimer disease. Nature Genet 1995;11:230-232
9. Rogaev EI, Sherrington R, Rogaev EAR, et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995;376:775-778
10. Lampe TH, Bird TD, Nochlin D, et al. Phenotype of chromosome 14-linked familial Alzheimer's disease in a large kindred. Ann Neurol 1994;36:368-378
11. Levy-Lahad E, Lahad A, Wijsman EM, et al. Apolipoprotein E genotypes and age of onset in early-onset familial Alzheimer's disease. Ann Neurol 1995;38:678-680
12. Sorbi S, Nacmias B, Forleo P, et al. Epistatic effect of APP717 mutation and apolipoprotein E genotype in familial Alzheimer's disease. Ann Neurol 1995;38:124-127
13. Hardy J, Houlden H, Collinge J, et al. Apolipoprotein E genotype and Alzheimer's disease. Lancet 1993;342:737-738
14. Van Broeckhoven C, Backhovens H, Cruts M, et al. APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease. Neurosci Lett 1994; 169:179-180
15. St George-Hyslop P, McLachlan DC, Tuda T, et al. Alzheimer's disease and possible gene interaction. Science 1994;263: 537